Aspen Pharmacare to Deliver J&J Vaccines in Next Three Months
- With technology transfer complete, company to test batches
- Drugmaker has capacity to build on 300 million-dose deal
A shipment of the Johnson & Johnson Janssen Covid-19 vaccine in Bay Shore, New York.
Photographer: Johnny Milano/BloombergThis article is for subscribers only.
Aspen Pharmacare Holdings Ltd. will supply the Covid-19 vaccine developed by Johnson & Johnson within the next three months, putting Africa’s biggest drugmaker “right up front of producing this vaccine globally,” Chief Executive Officer Stephen Saad said.
Since agreeing in November to produce as many as 300 million doses a year at its plant in Port Elizabeth, South Africa, Aspen has adopted the technology needed for production, Saad said in an interview Friday. The company has sufficient capacity to more than double that output if needed, he said.